FDA advisor who voted against recommending Pfizer’s Covid vaccine explains why she would ‘be first in line’ to get it

The Food and Drug Administration vaccine advisory panel signed off on Pfizer’s Covid vaccine with a 17 to four vote, with one abstention on Thursday evening. Dr. Archana Chatterjee, dean of the Chicago Medical School, was one of many 4 “no” votes. Chatterjee defined her choice throughout a Friday night interview on “The News with Shepard Smith.”

“I want to make it very clear that I am full in support of the authorization through this emergency use authorization process of the Pfizer- BioNTech coronavirus vaccine for use in adults 18-years-of-age and older,” Chatterjee stated. “The ‘no’ vote from me came because there was not the opportunity to vote on that question.”

Chatterjee defined to host Shepard Smith that the query positioned earlier than the committee was to embrace 16 and 17-year-olds. She stated she believed the quantity of knowledge that the panel had on the youthful contributors was very small, and was insufficient to make a willpower for that participant inhabitants. Chatterjee added that based mostly on her vote, she’d wait to give 16-year-olds the vaccine till there’s extra knowledge. 

Vaccine progress comes on the heels of the coronavirus pandemic’s deadliest week but in the United States. During an occasion hosted by the Council on Foreign Relations, Robert Redfield, director of the Centers for Disease Control and Prevention, stated that, “probably for the next 60 to 90 days, we’re going to have more deaths per day than we had on 9/11 or we had at Pearl Harbor.” At least 293,000 Americans have already died in the U.S. from Covid-19, according to knowledge from Johns Hopkins.

Nationwide, extra individuals are hospitalized with Covid-19 than ever earlier than, with greater than 107,000 hospitalized with the virus on Thursday, in accordance to the Covid Tracking Project. For context, that is the total capability of Michigan Stadium, the biggest stadium in the nation.

Chatterjee instructed Smith that she would “absolutely” get the vaccine. “If it was my priority risk group’s turn, I would be first in line,” she stated.

Chatterjee stated that her message to individuals who are afraid of getting the vaccine is that it is each secure and efficient. Pfizer knowledge confirmed that its vaccine was 95% efficient and had no critical uncomfortable side effects. 

“There were no major safety signals that would give us pause to not recommend this vaccine for authorization, so I would say the vaccine is safe and effective and will be one of the mechanisms through which we will get out of this deadly pandemic,” Chatterjee stated.  

Source hyperlink

What do you think?

Written by Business Boy


Leave a Reply

Your email address will not be published. Required fields are marked *



Cramer’s week forward: This is the time to speculate

FDA approves Pfizer’s Covid vaccine for emergency use as U.S. reaches pivotal moment in the pandemic